Aspen Pharmacare is considering more asset sales as part of its plans to reduce debt, says CEO Stephen Saad.

After the company reported results for the year to end-June this week, its shares rallied by more than 11% as the announcement also revealed debt had come down from R53.5bn to R38.9bn in the second half.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now